- Supported exchanges /
- F /
- 25I.F
IMMUPHARMA PLC LS-01 (25I F) stock market data APIs
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the P140 (Lupuzor), a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140 which is in Phase II for chronic inflammatory demyelinating polyneuropathy, a progressive inflammatory condition of the nerves; and P140 in other indications for asthma, gout, periodontitis, and IBD. Its pre-clinical products include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations for serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection treatment. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
IMMUPHARMA PLC LS-01 Financial Data Overview
| 0.01 | |
| 0.017 | |
| - | |
| 0.017 | |
| 0.01 | |
| 0.0002-0.04 | |
| 9 153 K | |
| 416 M | |
| -69 959 | |
| 1.534 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
IMMUPHARMA PLC LS-01 Fundamental Data is available in our Financial Data APIs
- Net Revenue -69 959
- EBITDA -2 558 742
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get IMMUPHARMA PLC LS-01 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get IMMUPHARMA PLC LS-01 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
